Laherradurin Inhibits Tumor Growth in an Azoxymethane/Dextran Sulfate Sodium Colorectal Cancer Model In Vivo

Michael Joshue Rendón-Barrón1,2, Eduardo Pérez-Arteaga1, Izamary Delgado-Waldo1

  • 1Unidad de Bioquímica, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Av. Vasco de Quiroga 15, Col. Belisario Domínguez Sección XVI, Tlalpan, Ciudad de México 14080, Mexico.

Cancers
|February 10, 2024
PubMed

Insights

Laherradurin, a natural compound from *Annona macroprophyllata*, shows significant antitumor effects against colorectal cancer (CRC) in mice. This compound reduced tumor size and promoted colon tissue recovery with less toxicity than cisplatin.

Area of Science:

  • Natural product chemistry
  • Oncology
  • Pharmacology

Background:

  • Colorectal cancer (CRC) presents a significant global health challenge with high mortality rates due to limited treatment options, metastasis, and chemoresistance.
  • Natural products are a vital source of novel bioactive molecules for cancer therapy.
  • Acetogenins (ACGs) are a class of compounds with demonstrated anticancer potential.

Purpose of the Study:

  • To evaluate the antitumor activity of laherradurin (LH), an acetogenin isolated from *Annona macroprophyllata*, in a preclinical model of colorectal cancer.
  • To compare the efficacy and toxicity of LH with cisplatin, a standard chemotherapy drug.

Main Methods:

  • Colorectal cancer was induced in Balb/c mice using the azoxymethane-dextran sulfate sodium (AOM/DSS) model.
  • Mice were treated for 21 days with either LH or cisplatin.
  • Tumor burden, histological changes, blood toxicity, apoptosis (TUNEL assay), and in vitro cell migration were assessed.

Main Results:

  • Laherradurin (LH) demonstrated significant antitumor activity, reducing both the number and size of colorectal tumors compared to cisplatin.
  • Histological examination revealed recovery of colon tissue architecture in LH-treated mice.
  • Blood toxicity analysis indicated less systemic damage in animals treated with LH compared to cisplatin.
  • TUNEL assays confirmed induction of apoptosis (programmed cell death) by LH.
  • In vitro studies showed that LH inhibited cell migration in HCT116 colorectal cancer cells.

Conclusions:

  • Laherradurin exhibits potent antitumor effects in a preclinical colorectal cancer model.
  • LH demonstrates a favorable safety profile with reduced toxicity compared to cisplatin.
  • LH warrants further investigation as a potential therapeutic agent for colorectal cancer.

Related Concept Videos